CCL2 and breast angiosarcoma: Several other inflammatory pathways have been implicated as possible mediators in BA, largely based on studies of the RRV-injected mouse model, including IL-12 [29], MCP-1 (CD46), MIP-2 (CXCL2), TNFα, and complement family members.